Replimune Group, Inc. Gains 101.33%
Wed, Jul 30, 2025 at 07:37 PM
Replimune Group, Inc. (REPL:NASDAQ) rocketted at $7.55, representing a gain of 101.3%. The stock appeared on our News Catalysts scanner on Wed, Jul 23, 2025 at 04:45 PM in the 'BIOTECH' category. From Wed, Jul 16, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Jul 21, 2025 at $13.24 with a volume of 4M+.
About Replimune Group, Inc. (REPL:NASDAQ)
Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Hempacco Co., Inc. (HPCO:NASDAQ), 800%
- Replimune Group, Inc. (REPL:NASDAQ), 101.33%
- XBP Europe Holdings, Inc. (XBP:NASDAQ), 81.09%
- SRM Entertainment, Inc. (SRM:NASDAQ), 53.27%
- Safe and Green Development Corporation (SGD:NASDAQ), 53.17%
- Super X AI Technology Ltd Ord (SUPX:NASDAQ), 43.98%
- 707 Cayman Holdings Limited (JEM:NASDAQ), 41.31%
- ATA Creativity Global (AACG:NASDAQ), 33.36%
- Top Wealth Group Holding Limited (TWG:NASDAQ), 29.31%